US1.5
AstraZeneca to build US$1.5 billion manufacturing plant in Singapore
ASTRAZENECA is planning to build a US$1.5 billion facility in Singapore to manufacture antibody drug conjugates (ADCs), or treatments that enable precision therapy for cancer.
AstraZeneca to build US$1.5 billion manufacturing plant in Singapore
ASTRAZENECA is planning to build a US$1.5 billion facility in Singapore to manufacture antibody drug conjugates (ADCs), or treatments that enable precision therapy for cancer.
Singapore-based Princeton Digital gets green loan for US$1.5 billion Asia AI hub
PRINCETON Digital Group secured a US$280 million green loan to help finance a US$1.5 billion data centre it’s building in southern Malaysia, a first for the Asian infrastructure operator...
- « Previous
- 1
- 2
- 3
- 4